Oasmia Pharmaceutical (OASMY) Stock Chart & Stock Price History $0.02 0.00 (0.00%) As of 07/25/2025 Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Oasmia Pharmaceutical Stock Price Performance The Oasmia Pharmaceutical (OASMY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.92%, with a year-to-date return of -50.00%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Oasmia Pharmaceutical traded at $0.02 with a market cap of and volume of 0 shares. Receive OASMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oasmia Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A OASMY Stock Chart for Monday, July, 28, 2025 OASMY Chart by TradingView Oasmia Pharmaceutical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel No price data in the selected date range. Related Companies BFRG Stock Price Chart BIVI Stock Price Chart FLGC Stock Price Chart MTVA Stock Price Chart TXMD Stock Price Chart PHIO Stock Price Chart CHHE Stock Price Chart BCDA Stock Price Chart IMUC Stock Price Chart SONN Stock Price Chart Receive OASMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oasmia Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OASMY) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBITCOINHow would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oasmia Pharmaceutical AB Please log in to your account or sign up in order to add this asset to your watchlist. Share Oasmia Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
